Matrix attachment region (MAR) properties and abnormal expansion of AT island minisatellites in FRA16B fragile sites in leukemic CEM cells

Nucleic Acids Research

Volumn 31, Issue 21, 2003, Pages 6354-6364

  Jackson, Jennifer A ^a   Trevino, Alex V ^a   Herzig, Maryanne C ^a   Herman, Terence S ^a   Woynarowski, Jan M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BIZELESIN; DNA MINISATELLITE; GENOMIC DNA; THYMINE;

ARTICLE; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA BINDING; DNA HYBRIDIZATION; DNA SEQUENCE; DOT HYBRIDIZATION; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

AT RICH SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CHROMOSOME FRAGILITY; CHROMOSOMES, HUMAN, PAIR 16; DNA; DNA SEQUENCE, UNSTABLE; GENES, MYC; GLOBINS; HUMANS; INDOLES; LEUKEMIA; MINISATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NUCLEAR MATRIX; NUCLEIC ACID CONFORMATION; POLYMERASE CHAIN REACTION; UREA;

EID: 0344442371     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg832     Document Type: Article

References (41)

1. Woynarowski,J.M., Trevino,A.V., Rodriguez,K.A., Hardies,S.C. and Benham,C.J. (2001) AT-rich islands in genomic DNA as a novel target for AT-specific DNA-reactive antitumor drugs. J. Biol. Chem., 276, 40555-40566.
2. Woynarowski,J.M. (2003) AT islands - their nature and potential for anticancer strategies. Curr. Cancer Drug Targets, in press.
3. Woynarowski,J.M., Napier,C., Trevino,A.V. and Arnett,B. (2000) Region-specific DNA damage by AT-specific DNA-reactive drugs is predicted by drug binding specificity. Biochemistry, 39, 9917-9927.
4. Herzig,M.C.S., Rodriguez,K.A., Trevino,A.V., Dziegielewski,J., Arnett,B., Hurley,L. and Woynarowski,J.M. (2002) The genome factor in region-specific DNA damage: The DNA-reactive drug U-78779 prefers mixed A/T-G/C sequences at the nucleotide level but is region-specific for long pure AT islands at the genomic level. Biochemistry, 41, 1545-1555.
5. Woynarowski,J.M. (2002) Targeting critical regions in genomic DNA with AT-specific anticancer drugs. Biochim. Biophys. Acta, 1587, 300-308.
6. Woynarowski,J.M. (2002) Preferential damage to defined regions of genomic DNA by AT-specific anticancer drugs. In Jones,G.B. and Chapman,E.J. (eds), Advances in DNA Sequence Specific Agents, Elsevier Press Inc., Vol. 4, pp. 1-27.
7. Debrauwere,H., Gendrel,C.G., Lechat,S. and Dutreix,M. (1997) Differences and similarities between various tandem repeat sequences: Minisatellites and microsatellites. Biochimie, 79, 577-586.
8. Bois,P. and Jeffreys,A.J. (1999) Minisatellite instability and germline mutation. Cell. Mol. Life Sci., 55, 1636-1648.
9. Richards,R.I. (2001) Fragile and unstable chromosomes in cancer: causes and consequences. Trends Genet., 17, 339-345.
10. Smith,D.I., Huang,H. and Wang,L. (1998) Common fragile sites and cancer (Review). Int. J. Oncol., 12, 187-196.
11. Rockwell,S., Yuan,J., Peretz,S. and Glazer,P.M. (2001) Genomic instability in cancer. Novartis Found. Symp., 240, 133-142; also 142-151.
12. Driouch,K., Prydz,H., Monese,R., Johansen,H., Lidereau,R. and Frengen,E. (2002) Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors. Oncogene, 21, 1832-1840.
13. Horwitz,M., Benson,K.F., Li,F.Q., Wolff,J., Leppert,M.F., Hobson,L., Mangelsdorf,M., Yu,S., Hewett,D., Richards,R.I. et al. (1997) Genetic heterogeneity in familial acute myelogenous leukemia: evidence for a second locus at chromosome 16q21-23.2. Am. J. Hum. Genet., 61, 873-881.
14. Popescu,N.C. (1994) Chromosome fragility and instability in human cancer. Crit. Rev. Oncog., 5, 121-140.
15. Huebner,K., Garrison,P.N., Barnes,L.D. and Croce,C.M. (1998) The role of the FHIT/FRA3B locus in cancer. Annu. Rev. Genet., 32, 7-31.
16. Mangelsdorf,M., Ried,K., Woollatt,E., Dayan,S., Eyre,H., Finnis,M., Hobson,L., Nancarrow,J., Venter,D., Baker,E. and Richards,R.I. (2000) Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res., 60, 1683-1689.
17. Ried,K., Finnis,M., Hobson,L., Mangelsdorf,M., Dayan,S., Nancarrow,J.K., Woollatt,E., Kremmidiotis,G., Gardner,A., Venter,D., Baker,E. and Richards,R.I. (2000) Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum. Mol. Genet, 9, 1651-1663.
18. Paige,A.J., Taylor,K.J., Stewart,A., Sgouros,J.G., Gabra,H., Sellar,G.C., Smyth,J.F., Porteous,D.J. and Watson,J,E. (2000) A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res., 60, 1690-1697.
19. Benham,C., Kohwi-Shigematsu,T. and Bode,J. (1997) Stress-induced duplex DNA destabilization in scaffold/matrix attachment regions. J. Mol. Biol., 274, 181-196.
20. Bode,J., Benham,C., Ernst,E., Knopp,A., Marschalek,R., Strick,R. and Strissel,P. (2000) Fatal connections: when DNA ends meet on the nuclear matrix. J. Cell. Biochem., 35 (Suppl), 3-22.
21. Berezney,R., Mortillaro,M.J., Ma,H., Wei,X. and Samarabandu,J. (1995) The nuclear matrix: a structural milieu for genomic function. Int. Rev. Cytol., 162A, 1-65.
22. Chernov,I.P., Akopov,S.B., Nikolaev,L.G. and Sverdlov,E.D. (2002) Identification and mapping of nuclear matrix-attachment regions in a one megabase locus of human chromosome 19q13.12: long-range correlation of S/MARs and gene positions. J. Cell. Biochem., 84, 590-600.
23. Kent,W.J., Sugnet,C.W., Furey,T.S., Roskin,K.M., Pringle,T.H., Zahler,A.M. and Haussler,A.D. (2002) The Human Genome Browser at UCSC. Genome Res., 12, 996-1006.
24. Kent,W.J. (2002) BLAT - the BLAST-like alignment tool. Genome Res., 12, 656-664.
25. Kramer,J.A., Singh,G.B. and Krawetz,S.A. (1996) Computer-assisted search for sites of nuclear matrix attachment. Genomics, 33, 305-308.
26. Woynarowska,B.A., Woynarowski,J.M., Herzig,M.C.S., Roberts,K., Higdon,A.L. and MacDonald,J.R. (2000) Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF). Biochem. Pharmacol., 59, 1217-1226.
27. Herzig,M.C., Trevino,A.V., Arnett,B. and Woynarowski,J.M. (1999) Tallimustine lesions in cellular DNA are AT sequence-specific but not region-specific. Biochemistry, 38, 14045-14055.
28. Fernandes,D.J., Smith-Nanni,C., Paff,M.T. and Neff,T.A. (1988) Effects of antileukemia agents on nuclear matrix-bound DNA replication in CCRF-CEM leukemia cells. Cancer Res., 48, 1850-1855.
29. Yu,S., Mangelsdorf,M., Hewett,D., Hobson,L., Baker,E., Eyre,H.J., Lapsys,N., Le Paslier,D., Doggett,N.A., Sutherland,G.R. Richards,R.I. (1997) Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell, 88, 367-374.
30. Jackson,J.A., Trevino,A.V., Herzig,M.C. and Woynarowski,J.M. (2002) Differential cytotoxicity of bizelesin in model tumor and normal cells parallels differences in abundance and nuclear organization of AT-rich fragile sites. Proc. Am. Assoc. Cancer Res., 43, 1092.
31. Park,J., Betel,D., Gryfe,R., Michalickova,K., Di Nicola,N., Gallinger,S., Hogue,C.W. and Redston,M. (2002) Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites. Cancer Res., 62, 1284-1288.
32. Chou,R.H., Churchill,J.R., Flubacher,M.M., Mapstone,D.E. and Jones,J. (1990) Identification of a nuclear matrix-associated region of the c-myc protooncogene and its recognition by a nuclear protein in the human leukemia HL-60 cell line. Cancer Res., 50, 3199-3206.
33. Chou,R.H., Churchill,J.R., Mapstone,D.E. and Flubacher,M.M. (1991) Sequence-specific binding of a c-myc nuclear-matrix-associated region shows increased nuclear matrix retention after leukemic cell (HL-60) differentiation. Am. J. Anat., 191, 312-320.
34. Djondjurov,L.P., Andreeva,M.M., Markova,D.Z. and Donev,R.M. (1994) Spatial and structural segregation of the transcribed and nontranscribed alleles of c-myc in Namalva-S cells. Oncol. Res., 6, 347-356.
35. Donev,R.M. (2000) The type of DNA attachment sites recovered from nuclear matrix depends on isolation procedure used. Mol. Cell. Biochem., 214, 103-110.
36. Goldman,J. and McGuire,W.A. (1992) H-ras and c-myc RNA expression in human T-cell ALL and in normal human lymphocytes. Pediatr. Hematol. Oncol., 9, 309-316.
37. McGuffie,E.M., Pacheco,D., Carbone,G.M. and Catapano,C.V. (2000) Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells. Cancer Res., 60, 3790-3799.
38. Handt,O., Sutherland,G.R. and Richards,R.I. (2000) Fragile sites and minisatellite repeat instability. Mol. Genet. Metab., 70, 99-105.
39. Hewett,D.R., Handt,O., Hobson,L., Mangelsdorf,M., Eyre,H.J., Baker,E., Sutherland,G.R., Schuffenhauer,S., Mao,J.I. and Richards,R.I. (1998) FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol. Cell, 1, 773-781.
40. Toledo,F., Coquelle,A., Svetlova,E. and Debatisse,M. (2000) Enhanced flexibility and aphidicolin-induced DNA breaks near mammalian replication origins: implications for replicon mapping and chromosome fragility. Nucleic Acids Res., 28, 4805-4813.
41. Svetlova,E.Y., Razin,S.V. and Debatisse,M. (2001) Mammalian recombination hot spot in a DNA loop anchorage region: a model for the study of common fragile sites. J. Cell. Biochem., 36 (Suppl), 170-178.